Effects of trimetazidine on plasma level of brain natriuretic peptide and clinical value of BNP in patients with chronic heart failure
Xiaosheng Fan, Bo Yin
Abstract
Xiaosheng Fan, Bo Yin
Abstract
Objective To observe the effects of trimetazidine on changes of plasma brain natriuretic peptide(BNP)and the clinical value of BNP in the diagnosis of chronic heart failure(CHF).Methods Sixtyeight patients with CHF were randomly divided into trimetazidine group and the conventional group,patients in the trimetazidine group were given trimetazidine 20 mg,tid,for 4 weeks.NYHA functional class,plasma BN-Pand echocardiographic indices(LVEDD,LVMI,LVEF)were evaluated before and after 4 weeks'therapy.Results After 4 weeks therapy,compared with the patients in the conventional group,trimetazidine improve cardiac function and reduce the Ievel of plasma BNP significantly.Conclusion Trimetazidine might improve cardiac function and reduce the level of plasma BNP in CHF patients,and plasma BNP might serve as a good indicator for evaluation of CHF and therapy in CHF patients. Key words: Heart failure; Trimetazidine; Brain natriuretic peptide
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effects of trimetazidine on changes of plasma brain natriuretic peptide(BNP)and the clinical value of BNP in the diagnosis of chronic heart failure(CHF).Methods Sixtyeight patients with CHF were randomly divided into trimetazidine group and the conventional group,patients in the trimetazidine group were given trimetazidine 20 mg,tid,for 4 weeks.NYHA functional class,plasma BN-Pand echocardiographic indices(LVEDD,LVMI,LVEF)were evaluated before and after 4 weeks'therapy.Results After 4 weeks therapy,compared with the patients in the conventional group,trimetazidine improve cardiac function and reduce the Ievel of plasma BNP significantly.Conclusion Trimetazidine might improve cardiac function and reduce the level of plasma BNP in CHF patients,and plasma BNP might serve as a good indicator for evaluation of CHF and therapy in CHF patients. Key words: Heart failure; Trimetazidine; Brain natriuretic peptide
Key concepts: Trimetazidine, Medicine, Brain natriuretic peptide, Internal medicine, Cardiology, Heart failure, Ejection fraction, Natriuretic peptide